California State Teachers Retirement System Insmed Inc Transaction History

California State Teachers Retirement System

  • $83.3 Billion
  • Q4 2024

A detailed history of California State Teachers Retirement System transactions in Insmed Inc stock. As of the latest transaction made, California State Teachers Retirement System holds 153,343 shares of INSM stock, worth $12.3 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
153,343
Previous 153,343 -0.0%
Holding current value
$12.3 Million
Previous $10.6 Million -0.0%
% of portfolio
0.01%
Previous 0.01%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
BUY
$66.29 - $76.63 $437,580 - $505,834
6,601 Added 4.5%
153,343 $10.6 Million
Q3 2024

Nov 14, 2024
BUY
$62.0 - $79.01 $496,496 - $632,712
8,008 Added 5.77%
146,742 $10.7 Million
Q2 2024

Aug 14, 2024
BUY
$22.0 - $69.71 $57,794 - $183,128
2,627 Added 1.93%
138,734 $9.3 Million
Q1 2024

May 15, 2024
SELL
$25.72 - $29.94 $214,093 - $249,220
-8,324 Reduced 5.76%
136,107 $3.69 Million
Q4 2023

Feb 13, 2024
SELL
$23.42 - $31.74 $124,196 - $168,317
-5,303 Reduced 3.54%
144,431 $4.48 Million
Q3 2023

Nov 14, 2023
SELL
$19.86 - $26.93 $281,316 - $381,463
-14,165 Reduced 8.64%
149,734 $3.78 Million
Q2 2023

Aug 21, 2023
SELL
$16.44 - $21.1 $88,956 - $114,172
-5,411 Reduced 3.2%
163,899 $3.46 Million
Q1 2023

May 09, 2023
SELL
$16.26 - $21.73 $16,422 - $21,947
-1,010 Reduced 0.59%
169,310 $2.89 Million
Q4 2022

Feb 14, 2023
BUY
$16.98 - $23.15 $346,239 - $472,051
20,391 Added 13.6%
170,320 $3.4 Million
Q3 2022

Nov 18, 2022
SELL
$20.88 - $28.21 $51,698 - $69,847
-2,476 Reduced 1.62%
149,929 $3.23 Million
Q2 2022

Aug 15, 2022
BUY
$17.07 - $25.71 $1,860 - $2,802
109 Added 0.07%
152,405 $3.01 Million
Q1 2022

May 16, 2022
SELL
$20.42 - $28.13 $187,292 - $258,008
-9,172 Reduced 5.68%
152,296 $3.58 Million
Q4 2021

Feb 15, 2022
BUY
$25.89 - $33.45 $167,327 - $216,187
6,463 Added 4.17%
161,468 $4.4 Million
Q3 2021

Nov 15, 2021
BUY
$22.46 - $29.47 $285,084 - $374,062
12,693 Added 8.92%
155,005 $4.27 Million
Q2 2021

Aug 16, 2021
SELL
$24.17 - $36.01 $250,304 - $372,919
-10,356 Reduced 6.78%
142,312 $4.05 Million
Q1 2021

May 18, 2021
SELL
$32.28 - $44.3 $19,432 - $26,668
-602 Reduced 0.39%
152,668 $5.2 Million
Q4 2020

Feb 16, 2021
BUY
$31.45 - $40.54 $220 - $283
7 Added 0.0%
153,270 $5.1 Million
Q3 2020

Nov 17, 2020
BUY
$26.0 - $34.5 $15,964 - $21,183
614 Added 0.4%
153,263 $4.93 Million
Q2 2020

Aug 17, 2020
BUY
$14.11 - $29.42 $244,258 - $509,289
17,311 Added 12.79%
152,649 $4.2 Million
Q1 2020

May 13, 2020
SELL
$13.63 - $33.98 $9,145 - $22,800
-671 Reduced 0.49%
135,338 $2.17 Million
Q4 2019

Feb 14, 2020
SELL
$16.12 - $24.98 $44,281 - $68,620
-2,747 Reduced 1.98%
136,009 $3.25 Million
Q3 2019

Nov 15, 2019
BUY
$15.49 - $25.78 $300,428 - $500,003
19,395 Added 16.25%
138,756 $2.45 Million
Q2 2019

Aug 14, 2019
BUY
$23.0 - $32.19 $48,484 - $67,856
2,108 Added 1.8%
119,361 $3.06 Million
Q1 2019

May 09, 2019
SELL
$13.91 - $31.15 $37,417 - $83,793
-2,690 Reduced 2.24%
117,253 $3.41 Million
Q4 2018

Feb 13, 2019
BUY
$11.6 - $18.7 $32,306 - $52,079
2,785 Added 2.38%
119,943 $1.57 Million
Q3 2018

Nov 14, 2018
SELL
$18.95 - $28.08 $776 - $1,151
-41 Reduced 0.03%
117,158 $2.37 Million
Q2 2018

Aug 14, 2018
BUY
$20.0 - $29.72 $13,480 - $20,031
674 Added 0.58%
117,199 $2.77 Million
Q1 2018

May 15, 2018
SELL
$21.69 - $32.99 $88,603 - $134,764
-4,085 Reduced 3.39%
116,525 $2.62 Million
Q4 2017

Feb 14, 2018
BUY
$26.43 - $31.78 $44,534 - $53,549
1,685 Added 1.42%
120,610 $3.76 Million
Q3 2017

Nov 13, 2017
BUY
$11.61 - $31.21 $1.38 Million - $3.71 Million
118,925
118,925 $3.71 Million

Others Institutions Holding INSM

# of Institutions
498
Shares Held
189M
Call Options Held
3.21M
Put Options Held
2.72M
View Full List

About INSMED Inc

INSM Quotes by TradingView
  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $10.8B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email